Full Schedule

08:00 - 09:00 CET

Moderated Oral/Video ePoster Sessions

09:00 - 10:45 CET

Plenary 03

Honorary Chair: – Istanbul Medipol University

Honorary Chair: – Tanta university, Egypt

09:00 - 09:03 CET

Welcome and Introductions

09:03 - 09:18 CET

SIU-Albert Schweitzer International Teaching Award Lecture

09:18 - 09:33 CET

Society Lecture

09:33 - 09:48 CET

Society Lecture

09:48 CET

Debate: Lymphadenectomy for Unfavorable Intermediate and High-risk Prostate Cancer for All or Risk-adapted

Moderator: – University of Michigan

09:48 - 09:58 CET

For All

Speaker:

09:58 - 10:08 CET

Risk Adapted

10:13 - 10:27 CET

Robotic Ureteral Reconstruction: From Grafts to Scaffolds

Speaker: – University of Queensland

10:27 - 10:41 CET

Game Changers in Endourology for KSD in 2026

Speaker: – "Saint John" Emergency Clinical Hospital

10:41 - 10:45 CET

Closing Remarks

10:45 - 11:15 CET

Networking Break

11:00 - 13:00 CET

Workshop: Lasers & Mists in LUTS/BPH

Co-Chair: – University of Toronto

11:15 - 12:45 CET

Instructional Course: Suction in Endourology

Endourology & Stones

11:15 - 12:45 CET

Joint Society of Urologic Oncology (SUO)/EAU Section of Oncological Urology (ESOU) Symposium

11:15 CET

The cT0 Conundrum & Evolving Standards

Bladder Cancer

11:30 CET

Debate: For a patient with persistent cT0 after neoadjuvant therapy, radical cystectomy is overtreatment

Bladder Cancer

11:15 - 12:45 CET

Master Class: Bladder Cancer: Bladder Preservation & Precision Management

Co-Chair: – Fox Chase Cancer Center

Co-Chair:

Co-Chair: – University of British Columbia

Bladder Cancer

11:15 - 11:20 CET

Does cT0 = pT0?

Speaker: – Fox Chase Cancer Center

Bladder Cancer

11:20 - 11:30 CET

Precision Clinical Staging (Starburst-1)

Speaker:

Bladder Cancer

11:30 - 11:37 CET

Pro

Bladder Cancer

11:37 - 11:44 CET

Con

Speaker:

Bladder Cancer

11:45 - 12:00 CET

Neoadjuvant Therapy

Speaker: – The Royal Marsden Foundation Trust

Bladder Cancer

12:00 - 12:15 CET

Aiming for Cure, Sparing the Bladder: The Art of Precision Radiotherapy

Speaker:

Bladder Cancer

12:15 - 12:25 CET

New clinical trials: NeoBlast

Speaker: – University of British Columbia

Bladder Cancer

12:25 - 12:45 CET

Panel Discussion/Q & A

Moderator:

Panelist: – Fox Chase Cancer Center

Panelist:

Panelist: – The Royal Marsden Foundation Trust

Panelist: – University of British Columbia

Bladder Cancer

11:15 - 12:45 CET

SIU International Mentorship Program for Longitudinal Enrichment (SIMPLE)

Chair: – Mass General Brigham | Harvard Medical School

11:15 - 11:25 CET

Suction Devices In Endourology

Endourology & Stones

11:25 - 11:45 CET

Procedure-Wise Application Video Based

Endourology & Stones

11:45 - 12:10 CET

Suction Within Ureteroscopes * Case-Based Discussion

Endourology & Stones

12:10 - 12:20 CET

Complications, Pitfalls And Troubleshooting

Endourology & Stones

12:20 - 12:45 CET

Summary - Key Messages and Take Home Points & Discussion

Endourology & Stones

12:45 - 14:00 CET

Networking Break

13:15 - 17:30 CET

11th SIU Global Nurses Educational Symposium

Co-Chair: – Memorial Sloan-Kettering Cancer Center

14:00 - 15:30 CET

Best ePoster Presentations

14:00 - 15:30 CET

Controversies in Urology: Locally Advanced Bladder Cancer - Multidisciplinary Management After Systemic Therapy Response

Co-Chair: – Aga Khan University

Co-Chair: – Rajiv Gandhi Cancer Institute & Research Centre

Bladder Cancer

14:00 - 14:08 CET

Evolving Standards of Systemic Therapy in Locally Advanced and Metastatic Bladder Cancer Based on Global Access

Bladder Cancer

14:08 - 14:16 CET

Imaging and staging of node-positive and M1a bladder cancer: CT vs PET and response assessment pitfalls

Bladder Cancer

14:16 CET

WHAT NEXT AFTER COMPLETE RESPONSE TO SYSTEMIC THERAPY IN N+/M1 DISEASE

Bladder Cancer

14:17 - 14:20 CET

DEBATE: N1/2 Disease After Response to Systemic Therapy - Post-response Local Management in N1/N2 Disease (Introduction)

Speaker: – Aga Khan University

Bladder Cancer

14:20 - 14:25 CET

Making a Case for Active Surveillance After Response in N1/2 Disease

Bladder Cancer

14:25 - 14:30 CET

Making a Case for Surgery After Response in N1/2 Disease

Bladder Cancer

14:30 - 14:35 CET

Making a Case for Bladder Preservation After Response in N1/2 Disease

Speaker:

Bladder Cancer

14:35 - 14:39 CET

N3 and M1a Disease After Response to Systemic Therapy (Introduction)

Bladder Cancer

14:39 - 14:47 CET

Local consolidative approaches in N3 and oligometastatic M1a disease

Speaker:

Bladder Cancer

14:47 - 14:55 CET

Would RC Ever Be an Option and Why?

Bladder Cancer

14:55 - 15:03 CET

Precision and Risk-adapted Management in Metastatic UC - Treatment Breaks, Surveillance and Intensification Strategies Using Ctdna/mrd After Major Response

Bladder Cancer

15:03 - 15:30 CET

Case-based Panel - N2 MIBC, Not Responding to Therapy

Moderator:

Bladder Cancer

14:00 - 15:30 CET

Hot Topic: Towards Perfection In Prostate Cancer Diagnosis

Prostate Cancer

14:00 - 14:15 CET

How Can We Reduce Metastatic Disease in the Developing World with Early Prostate Cancer Detection?

Speaker: – Beijing United Family Hospital And Clinics

Prostate Cancer

14:15 - 14:30 CET

How Does Micro-ultrasound Fit into the Diagnostic Pathway in the Era of MRI Prostate?

Prostate Cancer

14:30 - 14:45 CET

Is There a Synergistic Role of Biomarkers and Advanced Imaging in Optimizing Diagnosis of Prostate Cancer?

Speaker: – University of Michigan

Prostate Cancer

14:45 - 15:00 CET

Can We Forget PSA and Use Biparametric MRI Prostate as a First Line Screening Tool ?

Speaker: – University of Palermo

Prostate Cancer

15:00 - 15:15 CET

AI in Imaging and Pathology for Prostate Cancer: Hype or Game Changers?

Prostate Cancer

15:15 - 15:30 CET

Towards Prostate Cancer Diagnosis and Treatment Without a Biopsy

Speaker: – Medicity Guwahati

Prostate Cancer

14:00 - 15:30 CET

Instructional Course: Beyond the Standard: Selecting, Implanting, and Adjusting the Latest Adjustable Male Continence Devices

Voiding dysfunction

14:00 - 14:05 CET

Welcome and Setting the Stage

Voiding dysfunction

14:05 - 14:20 CET

Non-Surgical Paceycuff: Indications, Suitability, and Waiting List Use

Voiding dysfunction

14:20 - 14:45 CET

Adjustable Sling ATOMS: Surgical Technique, Post-Op Adjustment and Outcomes

Voiding dysfunction

14:45 - 15:10 CET

Artificial Sphincter Zephyr ZSI 375: Design, Implantation and Comparison to AUS

Speaker: – Royal Berkshire NHS trust

Voiding dysfunction

15:10 - 15:30 CET

Panel Q&A and Clinical Case Discussions

Voiding dysfunction

14:00 - 15:30 CET

Interactive Session: Flaps, Grafts and MESH in Women’s Health

Co-Chair: – WARANA INSTITUTE OF UROSURGERY, KOLHAPUR, INDIA

Reconstruction

14:00 - 14:12 CET

Advancing a Career in Reconstructive Urology

Reconstruction

14:12 - 14:24 CET

Mixed Urinary Incontinence in Women

Reconstruction

14:24 - 14:36 CET

Buccal Mucosa Graft in Urethral Stricture in Women

Speaker: – WARANA INSTITUTE OF UROSURGERY, KOLHAPUR, INDIA

Reconstruction

14:36 - 14:48 CET

Surgical Management of Urethral Diverticulum

Speaker: – UROKUL

Reconstruction

14:48 - 15:00 CET

Advances in Treatment of Ureteric Injuries and Strictures

Speaker: – Tanta university, Egypt

Reconstruction

15:00 - 15:12 CET

‘Less is more’ in pelvic organ prolapse treatment

Reconstruction

14:00 - 15:30 CET

Master Class: Artificial Intelligence in Urology - From Intelligent Operating Rooms to Digital Twin

Artificial Intelligence

14:00 - 14:10 CET

How Do We Standardise the Evaluation and Reporting of New AI Tools?

Artificial Intelligence

14:10 - 14:20 CET

AI, 3D Imaging, and Surgical Planning

Speaker: – HCG Cancer Center

Artificial Intelligence

14:20 - 14:30 CET

AI in Endoscopic Urology: Real-time Vision, Detection, and Support

Artificial Intelligence

14:30 - 14:40 CET

AI in Surgical Robots, Simulation, and Training

Artificial Intelligence

14:40 - 14:50 CET

AI Driven Interpretation and Educations in Surgical Operative Videos

Speaker: – Singapore General Hospital, Singapore

Artificial Intelligence

14:50 - 15:00 CET

AI in Pathology for Prostate and Bladder Cancer

Speaker:

Artificial Intelligence

15:00 - 15:10 CET

Human Digital Twins in Urology: Ethics and Responsibility

Artificial Intelligence

15:10 - 15:30 CET

Discussion & Q&A

Artificial Intelligence

15:12 - 15:30 CET

Discussion/Q&A

Reconstruction

16:00 - 17:30 CET

SIU Tips & Tricks: Office of Research